Chembio Diagn (CEMI) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- Exclusive-Silver Lake in talks to buy Workday, sources say
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Citi agrees to acquire rewards platform Kard Financial
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Total darkness, then sunset as full eclipse wows spectators in Spain
Chembio Diagnostics Reports First Quarter 2015 Financial Results
May 7, 2015 8:50 AM EDTMEDFORD, N.Y., May 7, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the three months ended March 31, 2015.
John J. Sperzel III, Chembio's Chief Executive Officer, stated, "In the first quarter, we achieved multiple important growth metrics. During the period our total revenue was $6.23 million, an increase of 7.2% as compared to Q1 2014. Product revenue for Q1 2015 was $5.61 million, an increase of 14.5% as compared to Q1 2014. One of the most important measures for the Company is DPP® revenue which was $2.46 million... More
Chembio Diagnostics Reports First Quarter 2015 Financial Results
May 7, 2015 8:50 AM EDTMEDFORD, N.Y., May 7, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today reported financial results for the three months ended March 31, 2015.
John J. Sperzel III, Chembio's Chief Executive Officer, stated, "In the first quarter, we achieved multiple important growth metrics. During the period our total revenue was $6.23 million, an increase of 7.2% as compared to Q1 2014. Product revenue for Q1 2015 was $5.61 million, an increase of 14.5% as compared to Q1 2014. One of the most important measures for the Company is DPP® revenue which was $2.46 million... More
